Verrica Pharmaceuticals buy Royal Bank of Canada
Start price
15.08.24
/
50%
€2.60
Target price
15.08.25
€11.83
Performance (%)
-77.02%
End price
16.08.25
-
Summary
This prediction is currently being closed. Massive losses of -77.02% have been the result for the BUY prediction by Royal_Bank_of_Canada. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verrica Pharmaceuticals | - | - | - |
| iShares Core DAX® | 0.754% | -1.027% | 14.485% |
| iShares Nasdaq 100 | -2.859% | -4.266% | 2.185% |
| iShares Nikkei 225® | 4.946% | 5.736% | 25.355% |
| iShares S&P 500 | -1.254% | -2.357% | 1.146% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Verrica Pharmaceuticals
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its price target lowered by analysts at Royal Bank of Canada from $14.00 to $13.00. They now have an "outperform" rating on the stock.
Ratings data for VRCA provided by MarketBeat
In the thread Trading Verrica Pharmaceuticals
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Royal_Bank_of_Canada for Verrica Pharmaceuticals
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€1.27
04.10.24
04.10.24
€10.03
04.10.25
04.10.25
-53.06%
05.10.25
05.10.25
